Find Federal Grants
Radiological/Nuclear Medical Countermeasure Product Development Program (SBIR) (R43/R44 Clinical Trial Not Allowed)
National Institutes of Health · PA-18-525
Discovery of Molecular Targets for Pregnancy-Related/Induced Diseases and Development of Therapeutics to Prevent/Treat These Diseases (R01 - Clinical Trial Optional)
National Institutes of Health · PAR-18-511
Effects of In Utero Alcohol Exposure on Adult Health and Disease (R21 - Clinical Trial Optional)
National Institutes of Health · PA-18-508
Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp - Clinical Trial Not Allowed)
National Institutes of Health · PA-18-517
Ancillary Studies to the NIDDK Inflammatory Bowel Disease Genetics Consortium (R01- Clinical Trial Optional)
National Institutes of Health · RFA-DK-17-017
Consequences of amyloid protein polymorphisms in Alzheimer's disease (R01 - Clinical Trial Not Allowed)
National Institutes of Health · RFA-AG-18-025
Effects of In Utero Alcohol Exposure on Adult Health and Disease (R01 - Clinical Trial Optional)
National Institutes of Health · PA-18-507
National Institutes of Health · PA-18-376
National Institutes of Health · PA-18-474
Drug Repurposing for Conditions Affecting Neonates and Pregnant Women (R01 - Clinical Trial Optional)
National Institutes of Health · PAR-18-506
National Institutes of Health · PA-18-475
National Institutes of Health · PA-18-377
Ancillary Studies to the NIDDK Inflammatory Bowel Disease Genetics Consortium (R21 - Clinical Trial Optional)
National Institutes of Health · RFA-DK-17-018
Biobehavioral and Technological Interventions to Attenuate Cognitive Decline in Individuals with Cognitive Impairment or Dementia (R01 Clinical Trial Optional)
National Institutes of Health · PA-18-348
Health-professional Education Partnership Initiative (HEPI) (R25 Clinical Trial Not Allowed)
National Institutes of Health · RFA-TW-17-001
Namibia DREAMS/Twagamenwa Activity
South Africa USAID-Pretoria · 72067318RFA00001
Tissue Mapping Centers for the Human BioMolecular Atlas Program (U54 Clinical Trials Not Allowed)
National Institutes of Health · RFA-RM-17-027
Transformative Technology Development for the Human BioMolecular Atlas Program (UG3/UH3 Clinical Trials Not Allowed)
National Institutes of Health · RFA-RM-17-025
Synthetic Psychoactive Drugs and Strategic Approaches to Counteract Their Deleterious Effects (R01 )
National Institutes of Health · PAR-18-510
Synthetic Psychoactive Drugs and Strategic Approaches to Counteract Their Deleterious Effects (R03 Clinical Trial Optional)
National Institutes of Health · PAR-18-527